Editorial
Copyright ©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Oct 26, 2024; 12(30): 6339-6345
Published online Oct 26, 2024. doi: 10.12998/wjcc.v12.i30.6339
Clinical approach for pulmonary alveolar proteinosis in children
Anuvat Klubdaeng, Prakarn Tovichien
Anuvat Klubdaeng, Prakarn Tovichien, Department of Pediatrics, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand
Author contributions: Klubdaeng A and Tovichien P designed the overall concept, outlined the manuscript, reviewed the literature, and wrote and edited the manuscript; All authors have read and approved the final manuscript.
Conflict-of-interest statement: Anuvat Klubdaeng and Prakarn Tovichien have nothing to disclose.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: Https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Prakarn Tovichien, MD, Associate Professor, Department of Pediatrics, Faculty of Medicine Siriraj Hospital, Mahidol University, 2 Wanglang Road, Bangkok Noi, Bangkok 10700, Thailand. prakarn.tov@mahidol.edu
Received: March 12, 2024
Revised: July 2, 2024
Accepted: July 10, 2024
Published online: October 26, 2024
Processing time: 176 Days and 1.7 Hours
Core Tip

Core Tip: Both pulmonary alveolar proteinosis and X-linked agammaglobulinemia are rare diseases in children, each presenting unique challenges in diagnosis and treatment. This article aims to shed light on the clinical approach, diagnosis, and treatment processes for managing these conditions effectively.